Text size A number of biotechs have market values that are less than the cash on their balance sheets. Dreamstime It’s mid-February, and the beleaguered biotech sector is showing no real signs of reco...
Text size A number of biotechs have market values that are less than the cash on their balance sheets. Dreamstime It’s mid-February, and the beleaguered biotech sector is showing no real signs of reco...